Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: Cross-talk between MCP-1 and leukotriene B-4
A. Matsukawa et al., Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: Cross-talk between MCP-1 and leukotriene B-4, J IMMUNOL, 163(11), 1999, pp. 6148-6154
We investigated the involvement of monocyte chemoattractant protein (MCP)-1
in a murine model of septic peritonitis induced by cecal ligation and punc
ture (CLP), Initial studies demonstrated that CLP induced a dramatic increa
se in MCP-1 production in the peritoneum, followed by an increase in the re
cruitment of leukocytes, MCP-1 blockade with anti-MCP-l antiserum significa
ntly decreased the survival rate following CLP, which was accompanied by an
enhanced recovery of viable bacteria from the peritoneum, This was likely
due to the reduction in the recruitment and activation of both macrophages
and neutrophils, To understand the mechanisms whereby MCP-1 may influence n
eutrophil infiltration, levels of chemokines known to attract neutrophils w
ere monitored, which showed that peritoneal levels of macrophage-inflammato
ry protein (MIP)-2, KC, and MIP-1 alpha were not altered with anti-MCP-1 Ab
s, However, anti-MCP-l Abs reduced the peritoneal levels of leukotriene B-4
(LTB4) by 59%, The i,p, injection of MCP-1 into normal mice resulted in el
evated levels of LTB4 in the peritoneum, In vitro, MCP-1 stimulated the pro
duction of LTB, from peritoneal macrophages, in a dose-dependent manner, A
specific LTE, receptor antagonist (CP-105,696) inhibited CLP-induced recrui
tment of both neutrophils and macrophages, which was accompanied by a reduc
ed level of MCP-1 in the peritoneum, Finally, administration of CP-105,696
was extremely detrimental to the survival of mice following CLP, These expe
riments demonstrate that endogenous MCP-1 serves as an indirect mediator to
attract neutrophils via the production of LTB4, and suggest the cross-talk
can occur between MCP-1 and the lipid mediator LTB, during septic peritoni
tis.